SUBSCRIBE
SUBSCRIBE

Abata Therapeutics

NEWS
Business
BioSpace Movers & Shakers, May 6
Biopharma and life sciences companies from across the globe strengthen their leadership teams and boards with these Movers & Shakers.
May 5, 2022
 · 
6 min read
 · 
Alex Keown
Business
BioSpace Movers & Shakers, April 8
Onxeo, Amydis, eFFECTOR Therapeutics, Freenome, Urovant Sciences and others all added new guidance and perspectives to their C-suite this week.
April 7, 2022
 · 
10 min read
 · 
Alex Keown
Business
Top Life Sciences Startups to Watch in 2022
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
January 4, 2022
 · 
19 min read
 · 
Heather McKenzie
Business
Third Rock-Seeded Abata Aims Tregs, $95 Million at Autoimmune Diseases
The Third Rock Ventures-backed startup has a pipeline of Treg therapeutics aimed at multiple sclerosis, type 1 diabetes and inclusion body myositis.
June 23, 2021
 · 
3 min read
 · 
Alex Keown
AWARDS
  • NextGen Class of 2022
JOBS
IN THE PRESS
Press Releases
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
September 16, 2024
 · 
3 min read
Press Releases
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive Multiple Sclerosis
August 23, 2024
 · 
3 min read
Press Releases
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement of its Treg Cell Therapy Pipeline into Clinical Development
August 15, 2024
 · 
2 min read
FDA
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
July 9, 2024
 · 
3 min read
Genetown
Abata Therapeutics to Present and Participate in Upcoming Investor and Industry Events
August 28, 2023
 · 
2 min read
Genetown
Abata Therapeutics Announces Second Development Candidate, ABA-201, a Novel Treg Cell Therapy for the Treatment of Type 1 Diabetes
August 24, 2023
 · 
6 min read
Genetown
Abata Therapeutics to Present at Upcoming Investor and Industry Events in June
May 31, 2023
 · 
1 min read
Business
Abata Therapeutics Announces the Appointment of Leonard Dragone, M.D., Ph.D., as Chief Medical Officer
April 20, 2023
 · 
4 min read
Business
Abata Therapeutics Appoints David Kaufman, M.D., Ph.D., to its Board of Directors
March 9, 2023
 · 
3 min read
Business
Abata Therapeutics Appoints Ellen Cahir-McFarland, Ph.D., as Chief Scientific Officer
December 7, 2022
 · 
3 min read
Load More